Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic

  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Sunshine Biopharma Inc. - Warrant (NQ:SBFMW)

0.4499 +0.2299 (+104.50%)
Streaming Delayed Price Updated: 3:52 PM EDT, Apr 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,764
Open 0.4100
Bid (Size) 0.1651 (8)
Ask (Size) 0.8900 (1)
Prev. Close 0.2200
Today's Range 0.3600 - 0.4499
52wk Range 0.0445 - 0.9802
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Sunshine Biopharma Q2 Report Reveals Approximately 1,940% Increase In Cash & Cash Equivalents And 80% Decrease In Net Loss Within 6 Months
Sunshine Biopharma, Inc. (NASDAQ: SBFM) (NASDAQ: SBFMW) announced that it has filed its 2022 second-quarter report with the Securities and Exchange Commission. 
Via Benzinga
Sunshine Biopharma Reveals Potential Intellectual Property Position In Connection With Ongoing mRNA-As-Therapeutics-Agents Research
Photo credit: Patent application by Nick Youngson CC BY-SA 3.0 
Via Benzinga

Performance

YTD
+180.0%
+180.0%
1 Month
+149.9%
+149.9%
3 Month
+101.7%
+101.7%
6 Month
+328.5%
+328.5%
1 Year
+389.0%
+389.0%

More News

Read More
Sunshine Biopharma Files Patent Application Covering Recently Announced mRNA Molecules Found To Be Effective At Destroying Multidrug Resistant Cancer Cells
Via Benzinga
Sunshine Biopharma Sees Potential Multi-Billion Dollar Global Market Opportunity As Research Findings Reveal Effectiveness Against Multidrug-Resistant Cancer Cells
Via Benzinga
Sunshine Biopharma, Inc. Announces Pricing of $8 Million Private Placement Priced At-the-Market
Via Benzinga
Aegis Capital Corp. acted as Sole Bookrunner on an Uplist of an $8 Million Underwritten Public Offering for Sunshine Biopharma Inc. (NASDAQ: SBFM; SBFMW)
From Aegis Capital Corp.
Via AccessWire
Exposures COVID-19

Frequently Asked Questions

Is Sunshine Biopharma Inc. - Warrant publicly traded?
Yes, Sunshine Biopharma Inc. - Warrant is publicly traded.
What exchange does Sunshine Biopharma Inc. - Warrant trade on?
Sunshine Biopharma Inc. - Warrant trades on the Nasdaq Stock Market
What is the ticker symbol for Sunshine Biopharma Inc. - Warrant?
The ticker symbol for Sunshine Biopharma Inc. - Warrant is SBFMW on the Nasdaq Stock Market
What is the current price of Sunshine Biopharma Inc. - Warrant?
The current price of Sunshine Biopharma Inc. - Warrant is 0.4499
When was Sunshine Biopharma Inc. - Warrant last traded?
The last trade of Sunshine Biopharma Inc. - Warrant was at 04/17/25 03:52 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.